Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
出版年份 2018 全文链接
标题
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
作者
关键词
-
出版物
NATURE GENETICS
Volume 50, Issue 5, Pages 682-692
出版商
Springer Nature
发表日期
2018-04-13
DOI
10.1038/s41588-018-0086-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas
- (2017) Camilla Pilati et al. JOURNAL OF PATHOLOGY
- Mutations in the NOT Genes or in the Translation Machinery Similarly Display Increased Resistance to Histidine Starvation
- (2017) Martine A. Collart et al. Frontiers in Genetics
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Overexpression and knock-down studies highlight that a disintegrin and metalloproteinase 28 controls proliferation and migration in human prostate cancer
- (2016) Caroline Rudnicka et al. MEDICINE
- Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- (2016) Serena Nik-Zainal et al. NATURE
- Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk
- (2016) Eric A. Klein et al. UROLOGY
- Upregulation of miR-556-5p promoted prostate cancer cell proliferation by suppressing PPP2R2A expression
- (2015) Wei Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis
- (2015) Jonathan F. Goodwin et al. CANCER CELL
- Coordinate Loss of MAP3K7 and CHD1 Promotes Aggressive Prostate Cancer
- (2015) L. U. Rodrigues et al. CANCER RESEARCH
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Genomic Predictors of Outcome in Prostate Cancer
- (2015) Peter J. Boström et al. EUROPEAN UROLOGY
- Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
- (2015) Elena Castro et al. EUROPEAN UROLOGY
- Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer
- (2015) Martina Kluth et al. INTERNATIONAL JOURNAL OF CANCER
- Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
- (2015) Charles J Ryan et al. LANCET ONCOLOGY
- Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial
- (2015) Yohann Loriot et al. LANCET ONCOLOGY
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- Spatial genomic heterogeneity within localized, multifocal prostate cancer
- (2015) Paul C Boutros et al. NATURE GENETICS
- Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
- (2015) Colin S Cooper et al. NATURE GENETICS
- Targeting the MLL complex in castration-resistant prostate cancer
- (2015) Rohit Malik et al. NATURE MEDICINE
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- canSAR: an updated cancer research and drug discovery knowledgebase
- (2015) Joseph E. Tym et al. NUCLEIC ACIDS RESEARCH
- Castration radiosensitizes prostate cancer tissue by impairing DNA double-strand break repair
- (2015) Firas L. Tarish et al. Science Translational Medicine
- Distinctive Behaviors of Druggable Proteins in Cellular Networks
- (2015) Costas Mitsopoulos et al. PLoS Computational Biology
- Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression
- (2015) Kathrin Fischer et al. Frontiers in Oncology
- Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer
- (2015) Juan Miguel Mosquera et al. NEOPLASIA
- Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
- (2014) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: Study in African-American and Caucasian prostate cancer models
- (2014) Aijaz Parray et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical significance of different types ofp53gene alteration in surgically treated prostate cancer
- (2014) Martina Kluth et al. INTERNATIONAL JOURNAL OF CANCER
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- (2014) Emilie Lalonde et al. LANCET ONCOLOGY
- Integrative Analysis of FOXP1 Function Reveals a Tumor-Suppressive Effect in Prostate Cancer
- (2014) Ken-ichi Takayama et al. MOLECULAR ENDOCRINOLOGY
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer
- (2014) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
- (2014) Niccolo Bolli et al. Nature Communications
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- (2014) Julia L. Williams et al. Cancer Genetics
- Copynumber: Efficient algorithms for single- and multi-track copy number segmentation
- (2013) Gro Nilsen et al. BMC GENOMICS
- Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
- (2013) Joachim Weischenfeldt et al. CANCER CELL
- CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
- (2013) L. Burkhardt et al. CANCER RESEARCH
- Punctuated Evolution of Prostate Cancer Genomes
- (2013) Sylvan C. Baca et al. CELL
- TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth
- (2013) Garrett Daniels et al. ENDOCRINE-RELATED CANCER
- Somatic Alterations Contributing to Metastasis of a Castration-Resistant Prostate Cancer
- (2013) Michael L. Nickerson et al. HUMAN MUTATION
- Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressiveERGfusion-positive prostate cancers
- (2013) Antje Krohn et al. JOURNAL OF PATHOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Drugging cancer genomes
- (2013) Paul Workman et al. NATURE REVIEWS DRUG DISCOVERY
- canSAR: updated cancer research and drug discovery knowledgebase
- (2013) Krishna C. Bulusu et al. NUCLEIC ACIDS RESEARCH
- REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
- (2013) C. Svensson et al. NUCLEIC ACIDS RESEARCH
- Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers
- (2013) W. R. Polkinghorn et al. Cancer Discovery
- Deciphering Signatures of Mutational Processes Operative in Human Cancer
- (2013) Ludmil B. Alexandrov et al. Cell Reports
- The Life History of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
- (2012) Andrew V. Biankin et al. NATURE
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia
- (2012) Kim De Keersmaecker et al. NATURE GENETICS
- Protein interaction data curation: the International Molecular Exchange (IMEx) consortium
- (2012) Sandra Orchard et al. NATURE METHODS
- Objective assessment of cancer genes for drug discovery
- (2012) Mishal N. Patel et al. NATURE REVIEWS DRUG DISCOVERY
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- FOXO1 Inhibits Runx2 Transcriptional Activity and Prostate Cancer Cell Migration and Invasion
- (2011) H. Zhang et al. CANCER RESEARCH
- CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression
- (2011) Z Liu et al. CELL DEATH AND DIFFERENTIATION
- Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types
- (2011) Siân Jones et al. HUMAN MUTATION
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11
- (2011) Masato Sasaki et al. NATURE MEDICINE
- Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer
- (2011) W Liu et al. ONCOGENE
- Fast and accurate long-read alignment with Burrows–Wheeler transform
- (2010) Heng Li et al. BIOINFORMATICS
- Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice
- (2010) Christelle Seigne et al. BMC CANCER
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
- (2010) X. Mao et al. CANCER RESEARCH
- Allele-specific copy number analysis of tumors
- (2010) P. Van Loo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads
- (2009) K. Ye et al. BIOINFORMATICS
- Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
- (2009) Jennifer C King et al. NATURE GENETICS
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
- (2009) Brett S Carver et al. NATURE GENETICS
- Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
- (2009) Wennuan Liu et al. NATURE MEDICINE
- Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor
- (2008) Kamilla Malinowska et al. ENDOCRINE-RELATED CANCER
- Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease
- (2008) Liesel M FitzGerald et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- SUMO-Specific Protease 1 (SENP1) Reverses the Hormone-Augmented SUMOylation of Androgen Receptor and Modulates Gene Responses in Prostate Cancer Cells
- (2008) Sanna Kaikkonen et al. MOLECULAR ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now